Skip to content

National Research Corporation NRC Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

TruBridge, Inc. logo
TruBridge, Inc.TBRG
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
Astrana Health logo
Astrana HealthASTH
RadNet logo
RadNetRDNT

Other financials

Income statement

See full
Revenue$34.8M+3.7%
Operating income$5.6M-35.8%
Net income$3.2M+11.1%
EPS (diluted)$12.50+4,708%

Balance sheet

See full
Cash & equivalents$2.5M+1.8%
Total debt$74.0M+26.2%
Total equity$13.5M-54.5%
Total assets$134.6M-0.5%

Cash flow

See full
Operating cash flow$7.2M+8.0%
CapEx$1.8M-38.6%
Free cash flow$5.3M+46.1%

Valuation

See full
Market cap$462.9M+22.8%
Enterprise value$534.37M+23.3%
P/E38.8×+21.3×
P/S3.3×+0.7×

Profitability

See full
Operating margin16.4%-8.2pp
Net margin8.6%-6.6pp
FCF margin12.6%+2.0pp

Returns & leverage

See full
Return on equity55.2%-9.3pp
Debt / equity5.5×+3.5×
Current ratio0.5×0.0×

Where this comes from

Reported directly by National Research Corporation in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: National Research Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Research Corporation's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is National Research Corporation's amortization expense related to capitalized debt issuance costs?
National Research Corporation (NRC) reported amortization expense related to capitalized debt issuance costs of $27K in Q1 2026.
How has National Research Corporation's amortization expense related to capitalized debt issuance costs changed year-over-year?
National Research Corporation's amortization expense related to capitalized debt issuance costs increased by 80.0% year-over-year, from $15K to $27K.
What is the long-term trend for National Research Corporation's amortization expense related to capitalized debt issuance costs?
Over 2 years (2023 to 2025), National Research Corporation's amortization expense related to capitalized debt issuance costs has grown at a 61.7% compound annual growth rate (CAGR), from $39K to $102K.